Optimizing Transition of Care in Multiple Myeloma: Bridging the Gap Between Academic and Community Settings : Episode 1
Identifying Potential Candidates for CAR T-Cell Therapy
A panel of experts on multiple myeloma introduce themselves and discuss the initial process of identifying patients who are potential candidates for CAR T-cell therapy.
- Could you describe the initial process of identifying and referring potential candidates for CAR T-cell therapy from the community setting to an academic center?
- What patient specific factors might you consider?
- Are there any criteria that patients need to meet in order to be ready to move to a community setting?Does this vary between community settings?
- What are some challenges you are seeing when transitioning from community to academic settings?
Recent Videos
Related Content
Considering NCCN Guidelines to Determine Maintenance Therapy Multiple Myeloma
February 15th 2025Article
During the 66th American Society of Hematology Annual Meeting and Exposition, experts in multiple myeloma gathered to discuss the impact of maintenance therapy and minimal residual disease (MRD) in patients with newly diagnosed transplant-eligible or -ineligible multiple myeloma.
